Skip to content

MamaLift Plus

by Curio Digital Therapeutics, Inc.

510(k) K223515

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 5 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 5 Oct 2026.

Regulatory status

as of registry sync 5 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK223515 Date22 Apr 2024ClearedStatusActive

Official records

From the FDA record

Received by the FDA
22 Nov 2022
FDA decision
22 Apr 2024 (Substantially Equivalent)
FDA review time
517 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K223515 (openFDA), as read on 5 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
SAP
Device class
Class II
Regulation
21 CFR Part 882.5801
Advisory committee
Neurology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

MamaLift Plus is a Computerized Behavioral Therapy Device for Depressive Disorders, classified as a Class II medical device under FDA regulation 882.5801. It is designed as a digital therapeutic to address symptoms of depressive disorders, specifically targeting postpartum depression (PPD). The device delivers structured, evidence-based behavioral therapy through an app-based platform, providing guided interventions and support for users.

MamaLift Plus is supplied as a software application, intended for use in home or outpatient settings. It is a single-use digital program, requiring no physical sterilization or reprocessing. The device operates without MRI compatibility concerns and is not subject to size or storage restrictions beyond standard electronic device requirements. Its FDA clearance (K223515) under the 510(k) pathway confirms regulatory compliance for symptomatic treatment of depressive disorders in the specified population.

Devices cleared under K223515

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K223515
UDI-DISize and differences
MamaLift Plus
Curio Digital Therapeutics, Inc.
MamaLift Plus00860012970308 —On the market

Other devices from Curio Digital Therapeutics, Inc.

  • MamaLift Plus

    Class II